Altered microbiome composition in individuals with fibromyalgia.

@article{Minerbi2019AlteredMC,
  title={Altered microbiome composition in individuals with fibromyalgia.},
  author={Amir Minerbi and Emmanuel Gonzalez and Nicholas James Beresford Brereton and Abraham Anjarkouchian and Ken Dewar and Mary-Ann Fitzcharles and St{\'e}phanie Chevalier and Yoram Shir},
  journal={Pain},
  year={2019}
}
Fibromyalgia (FM) is a prevalent syndrome, characterised by chronic widespread pain, fatigue and impaired sleep, that is challenging to diagnose and difficult to treat. The microbiomes of 77 women with FM and that of 79 control participants were compared using 16S rRNA gene amplification and whole genome sequencing. When comparing FM patients to unrelated controls using differential abundance analysis, significant differences were revealed in several bacterial taxa. Variance in the composition… 
[Investigating of Relation Between Fibromyalgia Syndrome and Intestinal Microbiota].
TLDR
The results suggest that the gut microbiota may play a role in fibromyalgia and large-scale further research in larger cohorts will be effective in understanding the relationship between the gut microbiome and FMS and evaluating possible treatment options.
An association between chronic widespread pain and the gut microbiome.
TLDR
Reduced diversity in the microbiome in CWP is demonstrated, indicating an involvement of the gut microbiota inCWP; prospectively the microbiome may offer therapeutic opportunities for this condition.
Gut microbiome: pertinence in fibromyalgia.
TLDR
These are merely the first steps in understanding the role of the gut microbiome in chronic pain and specifically FM, one might envision exciting future perspectives for better mechanistic understanding of FM, for the development of objective diagnostic aids and potentially for new therapeutic modalities.
Dietary Intake Is Unlikely to Explain Symptom Severity and Syndrome-Specific Microbiome Alterations in a Cohort of Women with Fibromyalgia
TLDR
The data demonstrate that dietary intakes, as evaluated by self-reported questionnaires, probably cannot explain the syndrome-specific differences in gut microbiome or the clinical phenotype of fibromyalgia.
Association Between Abundance of Haemophilus in the Gut Microbiota and Negative Symptoms of Schizophrenia
TLDR
The study findings suggest that alterations in certain gut microbiota may interfere with psychological symptoms in schizophrenia, and provide evidence that may help in the development of therapeutic strategies using microbial-based targets.
Metabolomics and Microbiomics: New Potential Strategies in Chronic Pain Syndrome
TLDR
Patients may benefit from the possibility of being stratified and classified based on their metabolic and microbial profile, which, in the next future, may lead to personalized therapy.
Metabolomics: The Key to Unraveling the Role of the Microbiome in Visceral Pain Neurotransmission
TLDR
The techniques used to analysis the metabolome, current potential metabolite targets for visceral hypersensitivity, and the current literature that evaluates the role of the post-inflammatory microbiota and metabolites in visceral hypers sensitivity are discussed.
The Effect of Multiprobiotics on Memory and Attention in Fibromyalgia: A Pilot Randomized Controlled Trial
TLDR
Results showed that treatment with a multispecies probiotic produced an improvement in attention by reducing errors on an attention task, but it had no effect on memory, and underline the relevance of using probiotics as a therapeutic option in FMS.
Gut Microbiome in Anesthesiology and Pain Medicine
TLDR
This article reviews basic concepts of the human gut microbiome and its interactions with the host and provides a comprehensive overview of the evidence linking the gut microbiome to anesthesiology, critical care, and pain medicine.
...
...

References

SHOWING 1-10 OF 114 REFERENCES
Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?
TLDR
A comprehensive review of the current evidence supporting microbiome alterations in ME/CFS patients is provided and the pitfalls and challenges associated with microbiome studies are discussed.
Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome
TLDR
Dysbiosis of the gut microbiota in this disease is indicated and an increased incidence of microbial translocation is suggested, which may play a role in inflammatory symptoms in ME/CFS.
Gut microbiome and chronic prostatitis/chronic pelvic pain syndrome.
TLDR
Newer microbiome research has found correlations between symptom scores and disease severity and the degree of dysbiosis in urine and gut microbiomes in these patients as compared to un-afflicted controls, which present potential new diagnostic and therapeutic targets in CP/CPPS patients.
Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome
TLDR
Findings indicate that dysbiotic features that are uniquely ME/CFS-associated may be masked by disturbances arising from the high prevalence of IBS co-morbidity in ME-CFS, and these insights may enable more accurate diagnosis and lead to insights that inform the development of specific therapeutic strategies in ME/ CFS subgroups.
The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment
TLDR
Altered alterations in the gut, dental or saliva microbiome distinguished individuals with RA from healthy controls, were correlated with clinical measures and could be used to stratify individuals on the basis of their response to therapy.
Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis
TLDR
The data suggest biomarkers identified in this study might participate in the pathogenesis or development process of ankylosing spondylitis, providing new leads for the development of new diagnostic tools and potential treatments.
Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome.
TLDR
The IPs in primary FM and, unexpectedly, CRPS are increased, and the implication of altered IP in the disease pathophysiology of FM and CRPS is stimulated.
Visceral hypersensitive rats share common dysbiosis features with irritable bowel syndrome patients.
TLDR
The dysbiosis MS rat model and the post-inflammatory rat model captured some of the Dysbiosis features of IBS patients and Fusobacterium, Clostridium XI and Porphyromonadaceae were identified as targets for future mechanistic research.
Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
TLDR
IBS symptom severity is found to be associated negatively with microbial richness, exhaled CH4, presence of methanogens, and enterotypes enriched with Clostridiales or Prevotella species.
...
...